很多年来,创新能力不强已成为中国医药行业管理者、经营者和有识之士“心中永远的痛”。创新能力不强是中国医药行业实现产业、产品和企业组织结构升级,以及实现产业和企业现代化国际化的最大制约因素。业界在企业采取什么样的创新方式、实施什么样的创新策略等方面都做过了很好的研究和探讨。 Over the years, the lack of innovation has become a “pain forever in the hearts of Chinese managers, managers and people of insight in the pharmaceutical industry.” The weak innovation ability is the biggest constraint for China’s pharmaceutical industry to upgrade the structure of industries, products and enterprises and to modernize its industries and enterprises. The industry in the enterprise to take what kind of innovative ways to implement what kind of innovation strategy have done a good research and discussion.